Stuttgart - Delayed Quote EUR
BioLife Solutions Inc (BJX1.SG)
21.40
+2.00
+(10.31%)
As of 4:41:43 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
82,254
82,254
75,855
76,239
119,156
Cost of Revenue
28,583
28,583
29,922
29,328
82,108
Gross Profit
53,671
53,671
45,933
46,911
37,048
Operating Expense
60,800
60,800
71,566
57,588
67,697
Operating Income
-7,129
-7,129
-25,633
-10,677
-30,649
Net Non Operating Interest Income Expense
-719
-719
-1,449
-284
-485
Other Income Expense
-3,577
-3,577
8,611
6,113
2,108
Pretax Income
-11,425
-11,425
-18,471
-4,848
-29,026
Tax Provision
-38
-38
-24
-5,236
-20,118
Net Income Common Stockholders
-20,184
-20,184
-68,002
-139,805
-8,908
Diluted NI Available to Com Stockholders
-20,184
-20,184
-68,002
-139,805
-8,908
Basic EPS
-0.44
--
-1.55
-3.29
-0.22
Diluted EPS
-0.44
--
-1.55
-3.29
-0.22
Basic Average Shares
46,067.07
--
43,719.19
42,481.03
38,503.94
Diluted Average Shares
46,067.07
--
43,719.19
43,073.47
38,503.94
Total Operating Income as Reported
-7,129
-7,129
-23,440
-5,923
-35,160
Total Expenses
89,383
89,383
101,488
86,916
149,805
Net Income from Continuing & Discontinued Operation
-20,184
-20,184
-68,002
-139,805
-8,908
Normalized Income
-7,326.55
-7,326.55
-25,745.50
-4,844.96
-10,235.87
Interest Expense
719
--
--
--
--
Net Interest Income
-719
-719
-1,449
-284
-485
EBIT
-7,129
-7,129
-25,633
-10,677
-30,649
EBITDA
1,532
1,532
-13,338
5,795
-17,784
Reconciled Cost of Revenue
22,659
22,659
21,147
16,846
77,445
Reconciled Depreciation
8,661
8,661
12,295
16,472
12,865
Net Income from Continuing Operation Net Minority Interest
-11,387
-11,387
-18,447
388
-8,908
Total Unusual Items Excluding Goodwill
-4,074
-4,074
7,308
5,451
1,819
Total Unusual Items
-4,074
-4,074
7,308
5,451
1,819
Normalized EBITDA
5,606
5,606
-20,646
344
-19,603
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-13.55
-13.55
9.50
218.04
491.13
12/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade